ABSTRACT
Semin Respir Infect 1997; 12:206-218. 5. Drutz DJ, Catanzaro A. Coccidiodomycosis: state of the art, part 1. Am Rev Respir Dis 1979;
120:911-938. 6. Goodwin RA Jr, DesPrez RM. Histoplasmosis: state of the art. Am Rev Respir Dis 1978; 117:
929-956. 7. Lorholary O, Meyohas MC, DuPont B, et al. Invasive aspergillosis in patients with acquired
immunodeficiency syndrome: report of 33 cases. Am J Med 1993; 95:177-187. 8. Sarosi GA, Davies SF. Blastomycosis: state of the art. Am Rev Respir Dis 1979; 120:911-
938. 9. Sarosi GA, Davies SF. Concise review for primary-care physicians: therapy for fungal infec
tions. Mayo Clin Proc 1994; 69:1111-1117. 10. Sarosi GA, Davies SF. Fungal Diseases of the Lung. 2d ed. New York: Raven Press, 1993. 11. Schaffner A, Davis CE, Schaffner T, et al. In vitro susceptibility of fungi to killing by neutro
phil granulocytes discriminates between primary pathogenicity and opportunism. J Clin Invest 1986; 78:511-524.
